The Current State of Treatment for Radiation Retinopathy

Prevention is critical as therapy aims to limit further vision loss.

By Jonathan C. Tsui, MD, Apoorv P. Chebolu, MD, Brian L. Vanderbeek MD, MPH, MSCE

New Treatments for Ocular Melanoma

Therapeutic approaches being tested may provide novel alternatives with fewer side effects than plaque brachytherapy or proton beam radiotherapy.

By Bria L. George, PharmD, Maura Di Nicola, MD, Basil K. Williams Jr., MD

A Simple Guide for Treating Retinoblastoma

Combination therapy can improve outcomes.

By Vishal R. Raval, MD, Stacey G. Zahler, DO, MS, Arun D. Singh, MD

Steroid Options for Treatment of Uveitis

Consider each patient's individual needs for therapy.

By Russel Dinh, Brian K. Do, MD

The Retina Product Pavilion 2023

By Peter K. Kaiser, MD

Cell-free DNA in Noninvasive Diagnosis of Retinoblastoma

A blood test has new implications for diagnosis and management.

By David H. Abramson, MD, FACS, Jasmine H. Francis, MD, FACS

UPFRONT: Failure Is Not Trying

By Peter K. Kaiser, MD

CODING Q&A: A Guide to Coding Fundamentals

Understanding certain key principles will prevent denials and protect practice revenues.

By Matthew Baugh, MHA, COT, OCS, OCSR

UVEITIS CORNER: Current Clinical Trials in Uveitis

Routes of administration vary across trials.

By Sruthi Arepalli, MD

NEW PRODUCT APPLICATIONS: Improving Safety During Retinal Detachment Surgeries

Device offers a new way to drain subretinal fluid.

By Karen Appold, contributing writer

Clinical Trial Update June 2023

SUBSPECIALTY NEWS: New product launches in laser and surgery, progress on clinical trials in dry AMD, and more.

By Rochelle Nataloni, contributing writer